For: | Rios Rodriguez V, Llop M, Poddubnyy D. Hematopoietic and mesenchymal stem cells: a promising new therapy for spondyloarthritis? Immunotherapy 2017;9:899-911. [PMID: 29338611 DOI: 10.2217/imt-2017-0034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Navarro-Compán V, Ermann J, Poddubnyy D. A glance into the future of diagnosis and treatment of spondyloarthritis. Ther Adv Musculoskelet Dis 2022;14:1759720X221111611. [PMID: 35898564 DOI: 10.1177/1759720X221111611] [Reference Citation Analysis] |
2 | Hauzeur J. Quel futur pour les cellules-souches mésenchymateuses dans les affections ostéoarticulaires ? Revue du Rhumatisme Monographies 2020;87:225-228. [DOI: 10.1016/j.monrhu.2020.02.003] [Reference Citation Analysis] |
3 | Torgutalp M, Poddubnyy D. Emerging treatment options for spondyloarthritis. Best Practice & Research Clinical Rheumatology 2018;32:472-84. [DOI: 10.1016/j.berh.2019.01.014] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis] |